Vevye Ophthalmic Solution Trial for Meibomian Gland Dysfunction Underway
A clinical trial is evaluating the efficacy of Vevye® (cyclosporine 0.1%) in treating meibomian gland dysfunction over a 24-week period.
Therapeutic Area
Therapeutic area intelligence for Meibomian Gland Dysfunction with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.